Gene · 3273
Papers1,508
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,508
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Categorization of 33 computational methods to detect spatially variable genes from spatially resolved transcriptomics data. | ArXiv | 2024 | 38855546 | PubTator, text mining | PubMed |
| Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis. | Front Immunol | 2024 | 38707900 | PubTator, text mining | PubMed |
| The Association between Histidine-Rich Glycoprotein rs10770 Genotype and Recurrent Miscarriage in Iranian Women. | Biomed Res Int | 2024 | 38659607 | PubTator, text mining | PubMed |
| Extending BioMASS to construct mathematical models from external knowledge. | Bioinform Adv | 2024 | 38606187 | PubTator, text mining | PubMed |
| Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis. | Front Immunol | 2024 | 38469298 | PubTator, text mining | PubMed |
| [The plasma protein HRG is an important factor for preventing sepsis and maintaining homeostatic response]. | Nihon Yakurigaku Zasshi | 2024 | 38432918 | PubTator, text mining | PubMed |
| HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process. | Sci Rep | 2024 | 38365849 | PubTator, text mining | PubMed |
| Biomarkers of chronic airflow limitation and COPD identified by mass spectrometry. | ERJ Open Res | 2024 | 38348244 | PubTator, text mining | PubMed |
| Molecular Atlas of HER2+ Breast Cancer Cells Treated with Endogenous Ligands: Temporal Insights into Mechanisms of Trastuzumab Resistance. | Cancers (Basel) | 2024 | 38339304 | PubTator, text mining | PubMed |
| Plasma concentrations of histidine-rich glycoprotein in primary graft dysfunction after lung transplantation. | Interdiscip Cardiovasc Thorac Surg | 2024 | 38310334 | PubTator, text mining | PubMed |
| Genotype-dependent N-glycosylation and newly exposed O-glycosylation affect plasmin-induced cleavage of histidine-rich glycoprotein (HRG). | J Biol Chem | 2024 | 38272220 | PubTator, text mining | PubMed |
| Recent Advances in Metalloproteomics. | Biomolecules | 2024 | 38254704 | PubTator, text mining | PubMed |
| LASSO regression shows histidine and sphingosine 1 phosphate are linked to both sepsis mortality and endothelial damage. | Eur J Med Res | 2024 | 38245777 | PubTator, text mining | PubMed |
| Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes. | Sci Rep | 2024 | 38182717 | PubTator, text mining | PubMed |
| A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene. | Thromb J | 2024 | 38169400 | PubTator, text mining | PubMed |
| Serum proteomic panel validated for prediction of knee osteoarthritis progression. | Osteoarthr Cartil Open | 2024 | 38116469 | PubTator, text mining | PubMed |
| Increased contact activated endogenous thrombin potential in pregnant women with preeclampsia. | Blood Coagul Fibrinolysis | 2024 | 38051647 | PubTator, text mining | PubMed |
| Chemokine platelet factor 4 accelerates peripheral nerve regeneration by regulating Schwann cell activation and axon elongation. | Neural Regen Res | 2024 | 37488866 | PubTator, text mining | PubMed |
| Iron homeostasis and post-hemorrhagic hydrocephalus: a review. | Front Neurol | 2023 | 38283681 | PubTator, text mining | PubMed |
| Exosome-Related FTCD Facilitates M1 Macrophage Polarization and Impacts the Prognosis of Hepatocellular Carcinoma. | Biomolecules | 2023 | 38254641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3273/papers?page=5